Assetmark Inc. Grows Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Assetmark Inc. increased its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 100.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 432 shares of the company’s stock after acquiring an additional 216 shares during the period. Assetmark Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $31,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in IHE. McElhenny Sheffield Capital Management LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the second quarter worth approximately $18,942,000. Aptus Capital Advisors LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at approximately $12,165,000. Rockport Wealth LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the second quarter worth approximately $12,091,000. Southern Capital Advisors LLC increased its stake in iShares U.S. Pharmaceuticals ETF by 1.1% in the 3rd quarter. Southern Capital Advisors LLC now owns 40,280 shares of the company’s stock worth $2,844,000 after buying an additional 448 shares in the last quarter. Finally, Commonwealth Equity Services LLC grew its position in shares of iShares U.S. Pharmaceuticals ETF by 7.3% during the second quarter. Commonwealth Equity Services LLC now owns 38,172 shares of the company’s stock worth $2,532,000 after purchasing an additional 2,589 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

iShares U.S. Pharmaceuticals ETF stock opened at $66.69 on Wednesday. The stock has a market cap of $673.57 million, a P/E ratio of 6.49 and a beta of 0.58. The firm’s 50 day moving average price is $70.24 and its 200-day moving average price is $68.72. iShares U.S. Pharmaceuticals ETF has a 1 year low of $57.62 and a 1 year high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.